Despite FDA warnings and federal measures, antipsychotic use rises and electroshock continues on vulnerable seniors. Intensive oversight is needed and an end to electroshock.
LOS ANGELES, CA, November 16, 2026 /24-7PressRelease/ -- A federal watchdog report has found that nursing homes continue using antipsychotics as chemical restraints, sometimes without first attempting required non-drug interventions. National data showed antipsychotic use among adults aged 65 and older increased nearly 52% between 2015 and 2024, while long-term use increased almost 65%.[1] The Citizens Commission on Human Rights (CCHR) International demands greatly increased oversight of the drugging of the elderly and the administration of electroshock treatment, a practice it says should be prohibited.
These recommendations align with a federal assessment that antipsychotic use among nursing home residents remains concerning despite a decade of efforts to reduce it. The drugs carry severe side effects for elderly people with dementia. The Food and Drug Administration (FDA) issued a boxed warning against their use in this population because of the increased risk of death.[2] Studies link newer antipsychotics in older adults with dementia to sharply higher risks of stroke, heart failure, accelerated cognitive decline, and bone fractures from falls.[3]
The Health and Human Services Office of Inspector General (OIG) has flagged the sedative effect of these drugs, raising concerns that nursing homes may use them to control residents' behavior for the benefit of staff. Investigators found that some medical directors failed to prevent inappropriate use, nursing home pharmacists did not identify medical concerns or recommend dose reductions, and inadequate policies undermined safeguards meant to protect residents.[4] This persists even though the Centers for Medicare & Medicaid Services has taken steps to discourage the practice.
The human cost is clear. Lori Smetanka, executive director of the National Consumer Voice for Quality Long-Term Care, notes: "Instead of getting to the root problem and addressing the problem, we're quieting them down. And then that's what leads to significant problems with their health and well-being."[5]
The risk extends further. Nearly every person diagnosed with dementia—up to an estimated 97%—will eventually experience changes in mood, perception or behavior.[6] This places them at risk of both psychotropic drugs and electroconvulsive therapy (ECT), also known as "electroshock"—the passage of up to 460 volts of electricity through the brain to induce a grand-mal seizure in frail bodies.
According to The New York Times, elderly persons have been electroshocked after they are already prescribed "so many other drugs that they cannot safely add a powerful psychiatric drug."[7] A psychiatrist writing in Ethical Human Psychology and Psychiatry warned that "ECT is especially devastating to the vulnerable brain and body of the elderly…. As would be predicted based on the fragility of the older brain, ECT causes more severe brain dysfunction in the elderly."[8]
Medicare data illustrate the scale of ECT use among seniors. Between 2012 and 2014, the program paid $29.6 million to physicians (excluding anesthesiologists) for administering and monitoring treatments; more than 125,500 ECT sessions occurred in 2014 alone. In 2018, 20,436 beneficiaries received nearly 116,000 treatments, with $31 million paid for the 2016–2018 period.
Cognitive harm is documented. A clinical neuropsychology study of 62 non-demented elderly depressed patients found that 40% showed significant individual-level decline within one week after ECT.[9]
Mortality risks are also elevated. In a 1993 Brown University study of patients 80 and older, 27% of those given ECT were dead within one year compared with 4% of a similar, untreated group; at two years the figures were 46% versus 10%.[10] The FDA has listed cardiac ischemia, arrhythmias, prolonged apnea, and death among potentially significant adverse events associated with ECT devices.[11]
ECT is not an FDA-approved indication for agitation in Alzheimer's disease or other dementias. Because the agency does not regulate the practice of medicine, psychiatrists may still administer it. The resulting confusion and memory loss can compound deficits already present in dementia.[12]
Jan Eastgate, president of CCHR International, states: "The cumulative picture is one of institutionalization that too often relies on drugs, ECT, and restraints rather than addressing root causes. This is the legacy of the widespread introduction of psychiatric treatment into the care of the elderly and requires intense oversight, an end to forced psychiatric treatment, and the adoption of safer alternatives."
CCHR encourages reporting psychiatric abuse of the elderly and advises individuals to contact their Congressional and state representatives about the abuse and demand strict enforcement of non-drug interventions and a prohibition on electroshock for all.
CCHR is a mental health watchdog established in 1969 by the Church of Scientology and psychiatrist Thomas Szasz, which investigates and exposes psychiatric abuses to protect vulnerable populations from harmful treatments.
Sources:
[1] "Meds Are Often the Go-to for Dementia Patients. Is There a Better Way?" Knowable Magazine, 26 Oct. 2026
[2] "Series: In-Depth Review of Nursing Home Citations Related to the Use of Antipsychotic Drugs," HHS, modified 16 Mar. 2026
[3] "Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study," The BMJ, 17 Apr. 2024; "Long-term antipsychotic use and cognitive decline in community-dwelling older adults with mild–moderate Alzheimer disease: Data from NILVAD," International Journal of Geriatric Psychiatry, 26 June 2021
[4] "Nursing Homes' Inappropriate Use of Antipsychotic Drugs Poses a Risk to Residents," HHS OIG, 16 Mar. 2026
[5] "Series: In-Depth Review of Nursing Home Citations...," HHS, modified 16 Mar. 2026
[6] "Meds Are Often the Go-to for Dementia Patients. Is There a Better Way?" Knowable Magazine, 26 Oct. 2026
[7] "F.D.A. Is Studying the Risk of Electroshock Devices," The New York Times, 23 Jan. 2011
[8] "The FDA Should Test the Safety of ECT Machines," Ethical Human Psychology and Psychiatry, Vol.12, Number 2, 2010
[9] "Cognitive Side-effects of Electroconvulsive Therapy in Elderly Depressed Patients," The Clinical Neuropsychologist, Vol. 28, 2014
[10] "Patients often aren't informed of full danger," USA Today, http://usatoday30.usatoday.com/life/health/lhs195.htm
[11] "FDA Executive Summary Prepared for the January 27-28, 2011 meeting of the Neurological Devices Panel Meeting to Discuss the Classification of Electroconvulsive Therapy Devices (ECT)," p. 6.
[12] https://www.cchrint.org/2021/05/17/cchr-urges-mental-health-month-oversight-of-elderly-being-electroshocked/
Citizens Commission on Human Rights (CCHR) is an international mental health industry watchdog, established by the Church of Scientology, which had helped enact more than 190 worldwide reforms that protect the public from abuse.
Read the original story here: https://www.24-7pressrelease.com/press-release/540497/cchr-demands-oversight-of-elderly-drugging-and-protection-from-electroshock
Press Release Service and Press Release Distribution by 24-7 Press Release Newswire
CCHR Demands Oversight of Elderly Drugging and Protection from Electroshock
Nov 16, 2026
What's Hot
More News
Press Releases
Clinton, CT Smart HVAC & Lighting Automation For Winter Prep...
Functional Nutrition for the WFH Life: How Busy Professional...
Nathan Stapleton-McKinzie's "Rainbow the Dragon" Captured Am...
Emerald Williams Selected to Super Lawyers Rising Stars 2022...
Bail Bonds Magazine Releases National Resource Hub With Info...




